Transcatheter Aortic Valve Replacement (TAVR)

Aortic stenosis (narrowing) is a potentially life-threatening condition. The aorta is the main artery carrying blood from the heart to the rest of the body. When blood leaves the heart, it flows through the aortic valve, into the aorta. In aortic stenosis, the aortic valve does not open fully. This condition decreases blood flow from the heart. In patients in whom the stenosis progresses and becomes severe, the result is a life-threatening condition.

What is Transcatheter Aortic Valve Replacement (TAVR)?

TAVR is an innovative procedure that offers a safe and effective alternative for the treatment of severe aortic stenosis, without the complications that can follow traditional valve replacement surgery. The minimally invasive method is used to replace the aortic valve but does not require removing the damaged valve, which eliminates the need for invasive open-heart surgery. Side effects are minimized, and the procedure is safe for those who are at high risk of complications from surgery. For some, TAVR offers a lifesaving option, where none existed for them before.

This offers new hope for low-risk, intermediate-risk and high-risk patients with severe symptomatic aortic stenosis in need of valve replacement surgery. Without valve replacement, studies indicate that more than half of all patients with severe aortic stenosis will not survive an average of two years. Unfortunately, many of these patients are too ill to undergo open valve replacement surgery. But now this new, less invasive approach is available for patients, even if they have significant other medical issues.

And, Stony Brook Heart Institute was among the first to offer this minimally invasive procedure to low-risk patients through its involvement in a low-risk TAVR clinical trial.

What are the benefits of TAVR?

For most patients, TAVR is performed as an outpatient procedure, requiring minimal sedation. Because it is a gentler procedure, recovery is quicker and easier. Generally, full recovery occurs within days. Patients at higher risks of complications may require a hospital stay of about 48 hours.

Leading the Way in Regional Heart Healthcare

Stony Brook Medicine is among the most experienced TAVR Centers in the nation, combining the latest minimally invasive advances with optimal personalized care. In 2012, our Heart Institute was the first in Suffolk County and one of the first in the country to introduce transcatheter aortic valve replacement (TAVR), an innovative and minimally invasive technique that has improved the lives of hundreds of our cardiac patients.

Why choose Stony Brook?

Our team is one of the region’s largest heart specialty groups, made up of nationally recognized surgeons and cardiologists. You can place your trust in the Stony Brook medical team, who has performed 500 TAVR procedures since the device was approved by the Food and Drug Administration in 2011. Ongoing clinical trials at Stony Brook Medicine also are paving the way for more patients to benefit from the minimally invasive surgical option TAVR offers.

At Stony Brook Medicine, our renowned Heart Institute team’s skill and experience provide world-class healthcare to Long Islanders right here close to home.

If you are a patient with severe aortic stenosis, or if you are a physician caring for a patient with this condition who could benefit from further evaluation, please call (631) 638-2101 to make an appointment, or to obtain more information about our TAVR program.


Our Team

Our multidisciplinary TAVR team has years of training and experience in cardiology including interventional cardiology and in cardiothoracic surgery, including valve surgery. This enables us to use the TAVR technology effectively in treating aortic stenosis and to provide comprehensive care for patients.

Our team includes:

  • Cardiovascular Imaging:
    Smadar Kort, MD, Director, Valve Center, Cardiology
    Noelle Mann, MD
    Howard Novotny, MD
    Jordan Katz, MD
  • Interventional Cardiologists:
    Robert Pyo, MD, Director, Catheterization Lab
    Puja Parikh, MD, FACC, FAHA, FSCAI, Co-Director, Transcatheter Aortic Valve Replacement Program
    Jonathan B. Weinstein, DO
    Neal Patel, MD
    Giridhar Korlipara, MD
    Shamin Khan, MD
    Daniel Montellese, MD
  • Cardiothoracic Surgeons:
    Henry Tannous, MD, Co-Director, Stony Brook Heart Institute; Chief, Cardiothoracic Surgery; and Surgical Director, Structural Heart Program
    Thomas Bilfinger, MD, Co-Director, Aortic Center and Director, Cardiothoracic Intensive Care Unit
  • Cardiac Anesthesiologists:
    Jeremy Poppers, MD, Director of Cardiac Anesthesia
    Elliott Bennett-Guerrero, MD
    Igor Izrailtyan, MD, FACC
    Renata Kowal, MD
    Peter Oleszak, MD
    Jeremy Poppers, MD, PhD, FASE
    Bharathi Scott, MD
    Eric Zabirowicz, MD
  • Valve Clinic Coordinator:
    Susan Callahan, NP
  • Cardiac Research Coordinator:
    Ruth Stein